Brief: Karyopharm Therapeutics Q2 Net Income USD 23.792 Million
Aug 06 (Reuters) - Karyopharm Therapeutics Q2 operating income USD -28.12 million. * Q2 product revenue USD 28.032 million * Q2 operating expenses USD 70.906 million * outlook FY revenue USD 145-160 million